Division of Endovascular Neurosurgery, Department of Neurological Surgery, Keck School of Medicine, University of Southern California, California, USA.
Division of Endovascular Neurosurgery, Department of Neurological Surgery, Keck School of Medicine, University of Southern California, California, USA.
World Neurosurg. 2023 Aug;176:e8-e13. doi: 10.1016/j.wneu.2023.01.057. Epub 2023 Jan 18.
Optimal management of acute ischemic stroke (AIS) secondary to intracranial atherosclerotic disease (ICAD) refractory to conventional mechanical thrombectomy remains unclear. We aimed to investigate the clinical outcome of patients undergoing rescue intracranial balloon angioplasty with or without stent placement in the setting of AIS in our institution.
This is a retrospective single-arm observational study to evaluate the efficacy and safety of rescue balloon angioplasty with or without stent placement in emergent large vessel occlusion (EVLO) strokes with underlying ICAD. We included all patients undergoing such rescue intervention within 24 hours of AIS presentation with EVLO between 2017 and 2021. We further evaluated stent or vessel reocclusion.
Of 20 patients undergoing rescue intervention, 3 cases achieved adequate recanalization of artery using balloon angioplasty alone. Seventeen patients required stent placement. Fourteen (70%) procedures resulted in National Institutes of Health Stroke Scale improvement in postprocedure and upon discharge. Among 6 (30%) procedures with worsening neurological measures, 3 had reoccluded stent 24-48 hours after procedure, 2 had symptomatic hemorrhagic conversion, and 1 had perforator occlusion. Nine patients (45%) had favorable functional outcome (modified Rankin Scale ≤2) at discharge, unchanged or improved at 3-month follow-up. The median modified Rankin Scale score was 4 (Interquartile range: 1.75-4) at discharge, improving to 3 (Interquartile range: 0-4) at 3-month follow-up. Two patients (10%) died during hospital stay.
Rescue angioplasty with or without stenting can lead to significant clinical improvement in patients with ICAD presenting with ELVO and refractory to thrombectomy; however, this procedure is associated with a high rate of morbidity in acute setting.
对于常规机械取栓治疗无效的颅内动脉粥样硬化性疾病(ICAD)继发的急性缺血性脑卒中(AIS),其最佳治疗策略仍不明确。本研究旨在探讨我院采用补救性颅内球囊血管成形术(BA)联合或不联合支架置入治疗 AIS 合并大血管闭塞(ELVO)患者的临床效果和安全性。
本研究为回顾性单臂观察性研究,纳入 2017 年至 2021 年我院收治的 AIS 发病 24 小时内行补救性治疗且存在 ELVO 且基础疾病为 ICAD 的患者。所有患者均接受补救性 BA 联合或不联合支架置入治疗。进一步评估支架或血管再闭塞情况。
20 例行补救性治疗的患者中,单纯球囊血管成形术即可使 3 例患者实现充分再通。17 例患者需要支架置入。术后和出院时,14 例(70%)患者美国国立卫生研究院卒中量表(NIHSS)评分改善。在 6 例(30%)神经功能恶化的患者中,3 例支架置入后 24-48 小时内发生支架再闭塞,2 例发生症状性脑出血转化,1 例发生穿支血管闭塞。出院时 9 例(45%)患者功能结局良好(改良 Rankin 量表≤2 分),3 个月随访时未发生变化或改善。出院时中位数改良 Rankin 量表评分为 4 分(四分位距:1.75-4),3 个月随访时改善至 3 分(四分位距:0-4)。2 例患者(10%)住院期间死亡。
补救性 BA 联合或不联合支架置入治疗可显著改善 ICAD 所致 ELVO 且对机械取栓治疗无效的患者的临床症状;但该治疗方法在急性发病时会带来较高的发病率。